What is the recommended dose of Augmentin (Amoxicillin/Clavulanate) for sinusitis and after how long of symptoms should it be initiated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025 • View editorial policy

From the Guidelines

Augmentin (Amoxicillin/Clavulanate) is recommended for sinusitis at a dose for 5 to 10 days.

  • The treatment should be initiated when symptoms of acute bacterial rhinosinusitis (ABRS) persist without improvement for at least 10 days beyond the onset of upper respiratory symptoms or worsen within 10 days after an initial improvement 1, 2.
  • The specific dose of Augmentin is not specified in the provided evidence, but the general recommendation is to prescribe amoxicillin with or without clavulanate as first-line therapy for 5 to 10 days for most adults 1.

Diagnosis and Management

  • Clinicians should distinguish presumed ABRS from viral upper respiratory infections and noninfectious conditions, and diagnose ABRS when symptoms or signs persist without improvement for at least 10 days or worsen within 10 days after an initial improvement 2.
  • Watchful waiting without antibiotics may be offered for adults with uncomplicated ABRS, with assurance of follow-up to start antibiotic therapy if the patient’s condition fails to improve by 7 days after diagnosis or worsens at any time 2.

From the FDA Drug Label

For more severe infections and infections of the respiratory tract, the dose should be one 875 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours. Table 1: Dosing in Patients Aged 12 weeks (3 months) and Older INFECTION | DOSING REGIMEN

                       | Every 12 hours          | Every 8 hours

Otitis media, sinusitis, | 45 mg/kg/day | 40 mg/kg/day lower respiratory tract | | infections, and more | | severe infections | |

The recommended dose of Augmentin (Amoxicillin/Clavulanate) for sinusitis is:

  • For patients aged 12 weeks (3 months) and older: 45 mg/kg/day every 12 hours or 40 mg/kg/day every 8 hours.
  • For patients weighing 40 kg or more: one 875 mg/125 mg amoxicillin and clavulanate potassium tablet every 12 hours or one 500 mg/125 mg amoxicillin and clavulanate potassium tablet every 8 hours. The label does not specify after how long of symptoms the treatment should be initiated 3.

From the Research

  • The recommended dose of Augmentin (Amoxicillin/Clavulanate) for sinusitis is 875 mg of amoxicillin with 125 mg of clavulanate, taken twice a day for 7-10 days 4, 5.
  • Some studies have investigated the use of high-dose amoxicillin/clavulanate, with doses of up to 2000 mg of amoxicillin per day, but the evidence suggests that this may not provide significant benefits over standard-dose therapy 4, 6.

Initiation of Augmentin Treatment

  • The decision to initiate Augmentin treatment for sinusitis should be based on the presence of symptoms and signs of acute bacterial sinusitis, such as purulent nasal discharge and maxillary or frontal pain, which have persisted for at least 48-72 hours 7, 5.
  • Treatment should be initiated as soon as possible after the diagnosis of acute bacterial sinusitis has been made, ideally within 3-5 days of the onset of symptoms 8.

Duration of Treatment

  • The duration of Augmentin treatment for sinusitis is typically 7-10 days, but some studies have investigated the use of shorter treatment courses, such as 5 days 8.
  • The choice of treatment duration should be based on the severity of symptoms, the presence of underlying medical conditions, and the response to treatment 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.